Carvedilol and metoprolol are both beta-blocker medications, which are a class of drugs used to treat various cardiovascular conditions like heart failure and hypertension (high blood pressure ...

Combining Carvedilol with certain foods, herbs, or alcohol & caffeine can trigger side-effects and alter the drug's efficacy. About Careers Internship MedBlog Contact us English (US) ...

They also showed that a low dose of carvedilol (e.g., <25 mg per day) is as effective as higher doses (e.g., 25–50 mg per day) at decreasing HVPG, with a lower risk of causing arterial hypotension.

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003;42:1944-1951. By Staff Writer, Medscape CRM ...

Of the 196 patients enrolled in the study, 182 were eligible, with 89 randomly assigned to carvedilol (up-titrated from 3.125 g per day to 12.5 mg per day) and 93 to placebo for 2 years.

We conducted a large-scale, prospective, randomized, double-blind, placebo-controlled trial of the effect of the beta-blocker carvedilol on the survival of patients with severe heart failure.

Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...

Moreover, similar protective findings for carvedilol (OR 0.01, 95% CI 0.0003-0.2958, P=0.0074) were reported even after further adjustment for coronary artery disease, not seen in other ...

In the U.S. Carvedilol Heart Failure Trials Program, 217 black and 877 nonblack patients (in New York Heart Association class II, III, or IV and with a left ventricular ejection fraction of no ...

Two preparations of carvedilol given to patients with heart failure were found nearly bioequivalent. Researchers for the Study to Compare the Effects of Coreg CR and Coreg IR on HF in Subjects ...

A total of 27,064 individuals were included in the study; 9558 (35.3%) and 17506 (64.7%) initiated carvedilol and metoprolol, respectively. Outcomes were assessed at a 1-year follow-up.

The widely prescribed beta blocker carvedilol has strong antiarrhythmic effects on the heart, but the underlying mechanisms have been unclear. Qiang Zhou et al. now show that carvedilol, unlike ...